TRAMETINIB for Neoplasm malignant: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 81 adverse event reports in the FDA FAERS database where TRAMETINIB was used for Neoplasm malignant.
Most Reported Side Effects for TRAMETINIB
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Pyrexia | 1,096 | 18.8% | 113 | 640 |
| Malignant neoplasm progression | 807 | 13.8% | 320 | 205 |
| Product use in unapproved indication | 349 | 6.0% | 33 | 36 |
| Diarrhoea | 325 | 5.6% | 42 | 183 |
| Nausea | 301 | 5.2% | 67 | 172 |
| Rash | 290 | 5.0% | 25 | 96 |
| Vomiting | 289 | 5.0% | 59 | 187 |
| Fatigue | 269 | 4.6% | 39 | 127 |
| Death | 240 | 4.1% | 240 | 40 |
| Chills | 227 | 3.9% | 29 | 128 |
| Asthenia | 193 | 3.3% | 42 | 92 |
| Drug ineffective | 192 | 3.3% | 77 | 53 |
| Anaemia | 184 | 3.2% | 32 | 124 |
| Off label use | 176 | 3.0% | 37 | 38 |
| Metastatic malignant melanoma | 173 | 3.0% | 119 | 75 |
Other Indications for TRAMETINIB
Metastatic malignant melanoma (1,604)
Malignant melanoma (1,448)
Product used for unknown indication (505)
Non-small cell lung cancer (191)
Colorectal cancer (158)
Glioma (139)
Braf gene mutation (94)
Neoplasm (84)
Braf v600e mutation positive (80)
Ovarian cancer (64)
Other Drugs Used for Neoplasm malignant
PALBOCICLIB (1,996)
CAPECITABINE (1,493)
PEMBROLIZUMAB (1,135)
PACLITAXEL (984)
CARBOPLATIN (977)
NIVOLUMAB (947)
OXALIPLATIN (823)
PAZOPANIB (716)
CYCLOPHOSPHAMIDE (685)
FLUOROURACIL (676)